Moreover, based on the expression of EMT hallmark genes including SNAI2, N-cadherin, Vimentin, ZEB1, ZEB2, SNAI1, Fibronectin, TWIST1 and E-cadherin, we found that patients with high risk score distinctly exhibited a mesenchymal phenotype, suggesting a higher tumor malignancy. This evidence concerns the gene SNAI2 and neoplasm.